Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | ACP3 | P15309 | 1/20 | 0.42 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3929537 | 1.00 | CYP2C9 (0.50) | CYP2C9CYP2C19ALDH1A1CYP1A2TSHR | |
| SCHEMBL6055148 | 0.89 | HPRT1 (0.48) | CYP2C9CYP2C19ALDH1A1CYP1A2TSHR | |
| SCHEMBL6933120 | 0.87 | LMNA (0.48) | CYP1A2TSHRKMT2ALMNAGAA | |
| SCHEMBL2734713 | 0.85 | ALDH1A1 (0.47) | CYP2C9CYP2C19ALDH1A1CYP1A2TSHR | |
| SCHEMBL30582816 | 0.84 | TSHR (0.44) | CYP2C9CYP2C19ALDH1A1CYP1A2TSHR | |
| SCHEMBL6313224 | 0.83 | TSHR (0.46) | CYP2C9CYP2C19ALDH1A1CYP1A2TSHR | |
| SCHEMBL22288132 | 0.83 | LMNA (0.42) | ALDH1A1CYP1A2TSHRKMT2ALMNA | |
| SCHEMBL7379765 | 0.82 | PPARG (0.46) | CYP2C9CYP2C19ALDH1A1CYP1A2TSHR | |
| SCHEMBL1527192 | 0.82 | ALDH1A1 (0.52) | CYP2C9CYP2C19ALDH1A1CYP1A2TSHR | |
| SCHEMBL28707980 | 0.82 | ALDH1A1 (0.52) | CYP2C9CYP2C19ALDH1A1CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4728019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Sable Rubber IP Pty Limited (AU) | 2026-04-22 | — | — | EP | disclosed |
| CN-121800659-A | Preparation method of fluoromethane naphthalenyl propanol | 四川大学 | 2026-04-07 | — | — | CN | disclosed |
| US-20250188376-A1 | SUSTAINABLE AVIATION FUELS | SARTEC CORPORATION | 2025-06-12 | — | — | US | disclosed |
| WO-2024257019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Molectra Rubber IP Pty Ltd (AU) | 2024-12-19 | — | — | WO | disclosed |
| CN-117486673-A | Method for synthesizing naphthalene group-containing propargyl fluoride compound by using sulfur hexafluoride | 国网安徽省电力有限公司电力科学研究院 | 2024-02-02 | — | — | CN | disclosed |
| US-20230416266-A1 | 6,7-DIHYDRO-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT | MERCK SHARP & DOHME LLC | 2023-12-28 | — | — | US | disclosed |
| EP-4247807-A1 | 6,7-DIHYDRO-PYRANO[2,3-D]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT | Merck Sharp & Dohme LLC (US) | 2023-09-27 | — | — | EP | disclosed |
| CN-114956933-A | Marker containing isotope oxygen atom and preparation method and application thereof | 清华大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-111517902-B | Aerobic oxidation system containing sulfinic acid, sulfonic acid or derivatives thereof and photo-oxidation promoting method thereof | 清华大学 | 2022-06-14 | — | — | CN | disclosed |
| WO-2022109485-A1 | 6,7-DIHYDRO-PYRANO[2,3-D]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT | MERCK SHARP & DOHME CORP. (US) | 2022-05-27 | — | — | WO | disclosed |
| US-5686486-A | 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl b!pyran-2-ones useful to treat retroviral infections | PHARMACIA & UPJOHN COMPANY (US) | 1997-11-11 | — | — | US | disclosed |
| EP-0788511-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-13 | — | — | EP | disclosed |
| EP-0603225-B1 | PROCESS FOR PRODUCING alpha-CHLOR-METHYLEN-TRIORGANYLPHOSPHORANE DERIVATES | BASF AG (DE) | 1997-06-04 | — | — | EP | disclosed |
| WO-1996011210-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-18 | — | — | WO | disclosed |
| EP-0682663-A1 | 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS | PHARMACIA & UPJOHN COMPANY (US) | 1995-11-22 | — | — | EP | disclosed |
| WO-1994023732-A1 | THERAPEUTIC PREPARATIONS CONTAINING CYPRESS TREE EXTRACTS AND METHODS OF USING SAME | KAMBOURAKIS MEDICINAL SOLUTIONS PTY. LIMITED (AU) | 1994-10-27 | — | — | WO | disclosed |
| WO-1994018188-A1 | 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL[B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS | THE UPJOHN COMPANY (US) | 1994-08-18 | — | — | WO | disclosed |
| EP-0603225-A1 | PROCESS FOR PRODUCING -g(a)-CHLOR-METHYLEN-TRIORGANYLPHOSPHORANE DERIVATES. | BASF AG (DE) | 1994-06-29 | — | — | EP | disclosed |
| WO-1993005053-A1 | PROCESS FOR PRODUCING α-CHLOR-METHYLEN-TRIORGANYLPHOSPHORANE DERIVATES | BASF AKTIENGESELLSCHAFT (DE) | 1993-03-18 | — | — | WO | disclosed |
| EP-0498680-A1 | New beta-amino-alpha-hydroxycarboxylic acids and their use | Sankyo Company Limited (JP) | 1992-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230416266-A1 | 6,7-DIHYDRO-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT | KRAS, NRAS, HRAS | CYP2C9 1721/4885CYP2C19 1557/4885ALDH1A1 1176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.